Literature DB >> 16918750

Why disclosure?

Raymond De Vries, Carl Elliott.   

Abstract

Mesh：

Year:  2006        PMID： 16918750      PMCID： PMC1831613          DOI： 10.1111/j.1525-1497.2006.00581.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  2 in total

1.  Panel faults Pfizer in '96 clinical trial in Nigeria.

Authors:  Joe Stephens
Journal:  Washington Post       Date:  2006-05-07

2.  Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.

Authors:  Kevin P Weinfurt; Joëlle Y Friedman; Jennifer S Allsbrook; Michaela A Dinan; Mark A Hall; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128
  2 in total
  1 in total

1.  The Sunshine Act: commercial conflicts of interest and the limits of transparency.

Authors:  Mark Wilson
Journal:  Open Med       Date:  2014-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.